Dr. Gele B. Moloney, MD

Dr. Moloney practices at UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Moloney's NPI, 1477785269, was assigned on August 13, 2009. Dr. Moloney graduated from State University of New York at Stony Brook, School of Medicine in 2009. Dr. Moloney holds Pennsylvania license MT195027.

Dr. Moloney's primary practice is UPMC Mercy, at 1400 Locust Street, Pittsburgh, PA 15219 in Allegheny County. The practice phone is (412) 232-8111.

Dr. Moloney's primary practice is UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Moloney is also affiliated with UPMC Magee-Womens Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Moloney to 2 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moloney practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Moloney's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Moloney is licensed in Pennsylvania.

CMS data shows 166 Medicare services from Dr. Moloney across 6 procedure codes in 2024, for 133 Medicare patients. Medicare paid $25,757 for them.

CMS counts 133 Medicare patients who saw Dr. Moloney in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have arthritis, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moloney's median patient age at 68, with 63% women.

In 2024, Dr. Moloney wrote 61 Medicare Part D claims for 34 patients. 97% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $57 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Moloney for performance year 2024, reported as part of a group. Dr. Moloney accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Moloney, published from 2012 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Fracture Fixation, Internal, Femoral Fractures and Bone Plates. Dr. Moloney has published most often in Injury. Dr. Moloney's most frequent co-authors are Peter A. Siska, MD, Stephen Ryan Chen and Mitchell Stephen Fourman, MD.

CMS Open Payments shows 107 general payments to Dr. Moloney from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 47% of the total. Synthes GmbH paid the most, $25,268.

Dr. Moloney graduated from State University of New York at Stony Brook, School of Medicine in 2009.